Home
Conditions
Myelodysplastic Syndrome

Clinical trial condition

Myelodysplastic Syndrome

Explore clinical trials studying Myelodysplastic Syndrome. Study availability and eligibility vary by location and protocol.

431 public trials 64 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndrome trial results

Completed

Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

NCT01048034

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +13 more
Locations: Department of Hematology, Aalborg University Hospital Aalborg, Denmark

Department of Hematology, Aarhus Univsersity Hospital Aarhus, Denmark

Department of Hematology, Rigshospitalet Univsersity Hospital Copenhagen, Denmark

Department of Hematology, Herlev Hospital Herlev, Denmark

View all 17 locations

View Trial Details

Completed

A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

NCT00619099

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Gabrail Cancer Center Canton, Ohio, United States

Landmark Medical Center Woonsocket, Rhode Island, United States

Sarah Cannon Research Nashville, Tennessee, United States

M. D. Anderson Houston, Texas, United States

View Trial Details

Completed

Erlotinib Study for Myelodysplastic Syndrome (MDS)

NCT00977548

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details

Completed

Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS)

NCT00882102

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)

NCT00744757

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Changhua, Taiwan

Kaohsiung City, Taiwan

Taichung, Taiwan

Tainan, Taiwan

View Trial Details

Completed

Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome

NCT00360672

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Study for Dacogen Treatment in Patients With Myelodysplastic Syndrome

NCT01041846

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Not specified

View Trial Details

Completed

Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies

NCT00697671

Conditions: Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Chronic Disease, +28 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies

NCT00807677

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Advanced Polycythemia, +47 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS

NCT00195000

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Weill Medcial College of Cornell University New York, United States

View Trial Details

Myelodysplastic Syndrome

Myelodysplastic Syndrome trial results

Related conditions